Shunt infections constitute one of the main risks of shunt surgery for hydrocephalus, which is the single most common type of surgery performed by pediatric neurosurgeons. Infectious complications are responsible for increased morbidity and mortality, lengthy hospitalizations, and high cost. Most modern series report infection rates approaching 10% of all shunt procedures. Despite the high incidence of this complication, optimal management is still unknown, and research on prevention has been hampered by single-institution series and small numbers. This article will review the history, causes, presentation, management, and outcome from shunt infections in children. Pitfalls in diagnosis and management will be reviewed. Finally, prevention strategies and research questions still remaining in this area will be outlined.
Get full access to this article
View all access options for this article.
References
1.
Nulsen FE, Spitz EB.Treatment of hydrocephalus by direct shunt from ventricle to jugular vein. Surg Forum.1952: 399-403.
2.
Boockvar J, Loudon W, Sutton LN.Development of the Spitz-Holter valve in Philadelphia. J Neurosurg. 2001; 95(1): 145-147.
3.
Drake JM, Kestle JR, Milner R, et al.Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery.1998; 43 (2): 294-303.
4.
Drake JM, Kestle JRW, Tuli S.CSF shunts 50 years on—past, present, and future. Childs Nerv Syst. 2000; 16: 800-804.
5.
Kestle J, Drake JM, Milner R, et al.Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg.2000: 230-236.
6.
Drake JM, Iantosca MR.Management of pediatric hydrocephalus with shunts. In: McClone DG, ed. Pediatric Neurosurgery: Surgery of the Developing Nervous System. 4th ed.Philadelphia: WB Saunders; 2001:505-522.
7.
Casey AT, Kimmings EJ, Kleinlugtebeld AD, et al.The long-term outlook for hydrocephalus in childhood. A ten-year cohort study of 155 patients. Pediatr Neurosurg. 1997; 27(2): 63-70.
8.
Pollack IF, Albright AL, Adelson PD.A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery.1999; 45 (6): 1399-1408.
9.
Kulkarni AV, Drake JM, Lamberti-Pasculli M.Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001; 94(2): 195-201.
10.
Hanlo PW, Cinalli G, Vandertop WP, et al.Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was used. J Neurosurg.2003; 99(1): 52-57.
11.
Mancao M, Miller C, Cochrane B, et al.Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr.1998; 87(6): 667-670.
Camboulives J, Meyrieux V, Lena G.Infections of cerebropinal fluid shunts in the child: prevention and treatment. Ann Fr Anesth Reanim.2002; 21(2): 84-89.
14.
McGirt MJ, Leveque JC, Wellons JCr, et al.Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg.2002; 36(5): 248-255.
15.
Shapiro S, Boaz J, Kleiman M, et al.Origin of organisms infecting ventricular shunts. Neurosurgery.1988; 22: 868-875.
16.
Patriarca PA, Lauer BA.Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae. Pediatrics.1980; 65(5): 1007-1009.
17.
Duhaime AC, Bonner K, McGowan KL, et al.Distribution of bacteria in the operating room environment and its relation to ventricular shunt infections: a prospective study. Childs Nerv Syst.1991; 7: 211-214.
Davis SE, Levy ML, McComb JG, Masri-Lavine L.Does age or other factors influence the incidence of ventriculoperitoneal shunt infections?Pediatr Neurosurg. 1999; 30(5): 253-257.
20.
Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM.Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg.2001; 35 (2): 66-71.
21.
Kontny U, Hofling B, Gutjahr P, et al.CSF shunt infections in children. Infection. 1993; 21(2): 89-92.
22.
Noetzel MJ, Baker RP.Shunt fluid examination: risks and benefits in the evaluation of shunt malfunction and infection. J Neurosurg.1984; 61(2): 328-332.
23.
Lo TYM, Myles LM, Minns RA.Longterm risks and benefits of a separate CSF access device with ventriculoperitoneal shunting in childhood hydrocephalus. Dev Med Child Neurol.2003; 45: 28-33.
24.
Sood S, Canady AI, Ham SD.Evaluation of shunt malfunction using shunt site reservoir. Pediatr Neurosurg.2000; 32: 180-186.
25.
Bruinsma N, Stobberingh EE, Herpers MJHM, et al.Subcutaneous ventricular catheter reservoir and ventriculoperitoneal drain-related infection in preterm infants and young children. Clin Microbiol Infect.2000; 6: 202-206.
26.
Jimenez DF, Keating R, Goodrich JT.Silicone allergy in ventriculoperitoneal shunts. Childs Nerv Syst.1994; 10(1): 59-63.
27.
Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E.Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis. 1994; 20(1): 33-40.
28.
Pittman T, Williams D, Weber TR, et al.The risk of abdominal operation in children with ventriculoperitoneal shunts. J Pediatr Surg. 1992; 27(8): 1051-1053.
29.
Rekate HL, Yonas H, White RJ, Nulsen FE.The acute abdomen in patients with ventriculoperitoneal shunts. Surg Neurol.1979; 11(6): 442-445.
30.
Fischer G, Geobel H, Latta E.Penetration of the colon by a ventriculoperitoneal drain resulting in an intracerebral abscess. Zentralbl Neurochir.1983; 42(2): 155-160.
31.
Gaskill SJ, Marlin AE.Spontaneous bacterial peritonitis in patients with ventriculoperitoneal shunts. Pediatr Neurosurg.1997; 26(3): 115-119.
Miller PD, Pollack IF, Pang D, Albright AL.Comparison of simultaneous versus delayed ventriculoperitoneal shunt insertion in children undergoing myelomeningocele repair. J Child Neurol.1996; 11(5): 370-372.
34.
Tuli S, Drake JM, Lamberti-Pasculli M.Long-term outcome of hydrocephalus management in myelomeningoceles. Childs Nerv Syst.2003; 19: 286-291.
35.
Ammirati M, Raimondi AJ.Cerebrospinal fluid shunt infections in children. A study on the relationship between the etiology of hydrocephalus, age at the time of shunt placement, and infection rate. Childs Nerv Syst.1987; 3(2): 106-109.
36.
Enger PO, Svendsen F, Wester K.CSF shunt infections in children: experiences from a population-based study. Acta Neurochir.2003; 145(4): 243-248.
Whitlaw A.Repeated lumbar or ventricular punctures in newborns with intraventricular hemorrhage. Cochrane Database of Systematic Reviews. 2001; 1:CD000216.
39.
Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE.Risk of infection after cerebropinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir.1995; 136(1-2): 1-7.
40.
Quigley MR, Reigel DH, Kortyna R.Cerebrospinal fluid shunt infections. Report of 41 cases and a critical review of the literature. Pediatr Neurosci.1989; 15(3): 111-120.
41.
Bierbrauer KS, Storrs BB, McClone DG, et al.A prospective, randomized study of shunt function and infections as a function of shunt placement. Pediatr Neurosurg. 1990-91; 16(6): 287-291.
42.
Cochrane DD, Kestle J.Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001. European J Pediatr Surg. 2002; 12(Suppl 1): S6-S11.
43.
Cochrane DD, Kestle JRW.The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg. 2003; 38: 295-301.
44.
Frykberg T, Olden L.Infection as a cause of peritoneal catheter dysfunction in ventriculo-peritoneal shunting in children. Z Kinderchir.1983; 38 (Suppl 2): 84-86.
45.
Piatt JHJ.Cerebrospinal fluid shunt failure: late is different from early. Pediatr Neurosurg.1995; 23(3): 133-139.
46.
Lan CC, Wong TT, Chen SJ, et al.Early diagnosis of ventriculoperitoneal shunt infections and malfunctions in children with hydrocephalus. J Microbiol Immunol Infect.2003; 36(1): 47-50.
47.
Guitierrez FA, Raimondi AJ.Peritoneal cysts: a complication of ventriculoperitoneal shunts. Surgery.1976; 79(02): 188-192.
48.
Gaskill SJ, Marlin AE.Pseudocysts of the abdomen associated with ventriculoperitoneal shunts: a report of twelve cases and a review of the literature. Pediatr Neurosci.1989; 15(1): 23-26.
49.
Roitberg BZ, Tomita T, McClone DG.Abdominal cerebrospinal fluid pseudocyst: a complication of ventriculoperitoneal shunt in children. Pediatr Neurosurg.1998; 29(5): 267-273.
50.
Kumar R, Sahay S, Gaur B, Singh V.Ascites in ventriculoperitoneal shunt.Indian J Pediatr.2003; 70(11): 859-864.
Haffner D, Schindera F, Aschoff A, et al.The clinical spectrum of shunt nephritis. Nephrol Dial Transplant.1997; 12(6): 1143-1148.
53.
Bayston R, Rodgers J.Role of serological tests in the diagnosis of immune complex disease in infection of ventriculoatrial shunts for hydrocephalus. Eur J Clin Microbiol Infect Dis.1994; 13(5): 417-420.
54.
Vinchon M, Vallee L, Prin L, et al.Cerebro-spinal fluid eosinphilia in shunt infections. Neuropediatrics.1992; 23(5): 235-240.
55.
Pittman T, Williams D, Rathore M, et al.The role of ethylene oxide allergy in sterile shunt malfunctions. Br J Neurosurg.1994; 8(1): 41-45.
Steinbok P, Cochrane D, Kestle JR.The significance of bacteriologically positive ventriculoperitoneal shunt components in the absence of other signs of shunt infection. J Neurosurg.1996; 85(5): 985-986.
58.
James HE, Walsh JW, Wilson HD, et al.Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery.1980; 7(5): 459-463.
59.
Whitehead WE, Kestle JR.The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg.2001; 35: 205-210.
60.
Guevara JA, La Torre J, Denoya C, Zuccaro G.Microscopic studies in shunts for hydrocephalus. Childs Brain.1981; 8(4): 284-293.
61.
Arthur AS, Whitehead WE, Kestle JRW.Duration of antibiotic therapy for the treatment of shunt infection: a surgeon and patient survey. Pediatr Neurosurg. 2002; 36: 256-259.
62.
Hardie NA, Molgaard CA, Laws ER, et al.Incidence and effectiveness of cerebrospinal fluid shunts in Olmsted County, Minnesota, 1956-1981. Neuroepidemiology. 1986; 5(2): 95-104.
63.
Hunt GM, Holmes AE.Factors relating to intelligence in treated cases of spina bifida cystica. Am J Dis Child.1976; 130(8): 823-827.
64.
Jamjoon AG, Mohammed AA, al-Bookai A, et al.Multiloculated hydrocephalus related to cerebrospinal shunt infection. Acta Neurochir.1996; 138(6): 714-719.
65.
Choux M, Genitori L, Lang D, Lena G.Shunt implantation: reducing the incidence of shunt infection (review). J Neurosurg. 1992; 77(6): 875-880.
Mottolese C, Grando J, Convert J, et al.Zero rate of shunt infection in the first postoperative year in children—dream or reality?Childs Nerv Syst.2000; 16: 210-212.
68.
Schmidt K, Gjerris F, Osgaard O, et al.Antibiotic prophylaxis in cerebropinal fluid shunting: a prospective randomized trial in 152 hydrocephalic patients. Neurosurgery. 1985; 17(1): 1-5.
69.
Djindjian M, Febrier MJ, Otterbein G, Soussy JC.Oxacillin prophylaxis in cerebrospinal fluid shunt procedures: results of a randomized open study in 60 hydrocephalic patients. Surg Neurol.1986; 25(2): 178-180.
70.
Rieder MJ, Frewen TC, Del Maestro RF, et al.The effect of cephalothin prophylaxis on postoperative ventriculoperitoneal shunt infections. Can Med Assoc J. 1987; 136(9): 935-938.
71.
Blum J, Schwarz M, Voth D.Antibiotic single-dose prophylaxis of shunt infections. Neurosurg Rev. 1989; 12(3): 239-244.
72.
Walters BC, Goumnerova L, Hoffman HJ, et al.A randomized controlled trial of perioperative rifampin/tripmethoprim in cerebropsinal fluid shunt surgery. Childs Nerv Syst. 1992; 8(5): 253-257.
73.
Zentner J, Gilsbach J, Felder T.Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients. Neurosurg Rev.1995; 18(3): 169-172.
74.
Haines SJ, Walters BC.Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis. Neurosurgery.1994; 34(1): 89-92.
75.
Govender ST, Nathoo N, van Dellen JR.Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg.2003; 99(5): 831-839.
76.
Steinbok P, Cochrane D.Ventriculosubgaleal shunt in the management of recurrent ventriculoperitoneal shunt infection. Childs Nerv Syst.1994; 10 (8): 536-539.
77.
Jones RF, Stening WA, Kwok BC, Sands TM.Third ventriculostomy for shunt infections in children. Neurosurgery.1993; 32(5): 855-859.
78.
Siomin V, Cinalli G, Grotenhuis A, et al.Endoscopic third ventriculostomy in patients with cerebrospinal fluid infection and/or hemorrhage. J Neurosurg.2002; 97(3): 519-524.
79.
Smyth MD, Tubbs RS, Wellons JC, et al.Endoscopic third ventriculostomy for hydrocephalus secondary to central nervous system infection or intraventricular hemorrhage in children. Pediatr Neurosurg. 2003; 39(5): 258-263.
